Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta-analysis Study

  • Moghaddam, Ali Sanjari (The Collaboration Center of Meta-Analysis Research (ccMETA), Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences) ;
  • Nazarzadeh, Milad (The Collaboration Center of Meta-Analysis Research (ccMETA), Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences) ;
  • Moghaddam, Hossein Sanjari (School of Medicine, Tehran University of Medical Sciences) ;
  • Bidel, Zeinab (The Collaboration Center of Meta-Analysis Research (ccMETA), Iranian Research Center on Healthy Aging, Sabzevar University of Medical Sciences) ;
  • Karamatinia, Aliasghar (Department of Social Medicine, Shahid Beheshti University of Medical Sciences) ;
  • Darvish, Hossein (Department of Genetic, School of Medicine, Shahid Beheshti University of Medical Sciences) ;
  • Jarrahi, Alireza Mosavi (Department of Social Medicine, Shahid Beheshti University of Medical Sciences)
  • Published : 2016.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Breast cancer risk assessment has developed during years and evaluation of genetic factor affecting risk of breast cancer is an important component of this risk assessment. The aim of this meta-analysis was to investigate the role of XRCC1 polymorphisms (Arg194Trp, Arg280His and Arg399Gln) in risk of breast cancer among different population and categories of menopausal status.PubMed, Medline, Web of Science, and PubMed Central were systematically searched to identify studies evaluating association between breast cancer and XRCC1 gene polymorphisms (Arg194Trp, Arg280His and Arg399Gln). Two authors independently extracted required information. Odds Ratios were pooled for four genetic inheritance models using both fixed and the DerSimonian and Laird random-effect models. Egger's test and contour-enhanced funnel plot was used to evaluate publication bias and small study effect. Additional subgroup analysis was performed for menopausal status, ethnicity, and source of controls. After evaluation and applying inclusion criteria on extracted studies, fifty three studies were included in this meta-analysis. For polymorphisms of Arg194Trp and Arg280His, no significant association was observed in all genetic models. Arg194Trp had a protective effect in post-menopausal status only in homozygote model (OR=0.57 [0.37-0.88]). Arg399Gln showed significant association with breast cancer in homozygote (OR=1.21 [1.10-1.34]), dominant (OR=1.09 [1.03-1.15]) and recessive (OR=1.21 [1.09- 1.35]) genetic models. Arg399Gln was associated with higher risk in post-menopausal status for homozygote and heterozygote models. Our findings suggest that XRCC1 gene polymorphisms modify breast cancer risk in different populations and different categories of menopausal status.

Keywords

References

  1. Al Mutairi FM, Alanazi M, Shalaby M, et al (2013). Association of XRCC1 gene polymorphisms with breast cancer susceptibility in Saudi patients. Asian Pac J Cancer Prev, 14, 3809-13. https://doi.org/10.7314/APJCP.2013.14.6.3809
  2. Ali MF, Meza JL, Rogan EG, et al (2008). Prevalence of BER gene polymorphisms in sporadic breast cancer. Oncol Rep, 19, 1033-8.
  3. Armstrong K, Eisen A, Weber B (2000). Assessing the risk of breast cancer. NEJM, 342, 564-71. https://doi.org/10.1056/NEJM200002243420807
  4. Bertwistle D, Ashworth A (1998). Functions of the BRCA1 and BRCA2 genes. Curr Opin Genetics Dev, 8, 14-20. https://doi.org/10.1016/S0959-437X(98)80056-7
  5. Brewster AM, Jorgensen TJ, Ruczinski I, et al (2006). Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat, 95, 73-80. https://doi.org/10.1007/s10549-005-9045-3
  6. Bu D, Tomlinson G, Lewis CM, et al (2006). An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Res Treat, 99, 257-65. https://doi.org/10.1007/s10549-006-9210-3
  7. Bu T, Liu L, Sun Y, et al (2014). XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: a meta-analysis of 10846 cases and 11723 controls. PLoS One, 9, e86086. https://doi.org/10.1371/journal.pone.0086086
  8. Chacko P, Rajan B, Joseph T, et al (2005). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat, 89, 15-21. https://doi.org/10.1007/s10549-004-1004-x
  9. Consortium BCA (2006). Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst, 98, 1382-96. https://doi.org/10.1093/jnci/djj374
  10. Costa S, Pinto D, Pereira D, et al (2007). DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat, 103, 209-17. https://doi.org/10.1007/s10549-006-9364-z
  11. Deligezer U, Dalay N (2004). Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients. Exp Mol Med, 36, 572-5. https://doi.org/10.1038/emm.2004.73
  12. Ding P, Yang Y, Cheng L, et al (2014). The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women. PLoS One, 9, e92083. https://doi.org/10.1371/journal.pone.0092083
  13. Duell EJ, Millikan RC, Pittman GS, et al (2001). Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev, 10, 217-22.
  14. Dufloth RM, Costa S, Schmitt F, et al (2005). DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res, 4, 771-82.
  15. Feng YZ, Liu YL, He XF, et al (2014). Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies. Tumour Biol, 35, 10677-97. https://doi.org/10.1007/s13277-014-2326-x
  16. Figueiredo JC, Knight JA, Briollais L, et al (2004). Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev, 13, 583-91.
  17. Forsti A, Angelini S, Festa F, et al (2004). Single nucleotide polymorphisms in breast cancer. Oncol Rep, 11, 917-22.
  18. Han J, Hankinson SE, De Vivo I, et al (2003). A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Res, 63, 8536-41.
  19. Huang C-S, Chen J-J, Yang S-Y, et al (2004). Breast Cancer Risk Associated with Genotypic Polymorphism of Oxidative DNA Damage Repair Genes-A Multigenic Study of Base Excision Repair and Transcription-Coupled Repair in Cancer Susceptibility. J Genet Mole Biol, 15, 116-36.
  20. Huang Y, Li L, Yu L (2009). XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis, 24, 331-9. https://doi.org/10.1093/mutage/gep013
  21. Hussien YM, Gharib AF, Awad HA, et al (2012). Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients. Mol Biol Rep, 39, 1895-901. https://doi.org/10.1007/s11033-011-0935-7
  22. Jakubowska A, Gronwald J, Menkiszak J, et al (2010). BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat, 119, 201-11. https://doi.org/10.1007/s10549-009-0390-5
  23. Jelonek K, Gdowicz-Klosok A, Pietrowska M, et al (2010). Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet, 51, 343-52. https://doi.org/10.1007/BF03208865
  24. Key TJ, Verkasalo PK, Banks E (2001). Epidemiology of breast cancer. Lancet Oncol, 2, 133-40. https://doi.org/10.1016/S1470-2045(00)00254-0
  25. Kim S-U, Park SK, Yoo K-Y, et al (2002a). XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenet Genomics, 12, 335-8.
  26. Kim SU, Park SK, Yoo KY, et al (2002b). XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics, 12, 335-8. https://doi.org/10.1097/00008571-200206000-00010
  27. Kipikasova L , Wolaschka T, Bohus P, et al (2008). Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study. Pathol Oncol Res, 14, 131-5. https://doi.org/10.1007/s12253-008-9034-z
  28. Lee E, Levine EA, Franco VI, et al (2014). Combined genetic and nutritional risk models of triple negative breast cancer. Nutr Cancer, 66, 955-63. https://doi.org/10.1080/01635581.2014.932397
  29. Lichtenstein P, Holm NV, Verkasalo PK, et al (2000). Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. NEJM, 343, 78-85. https://doi.org/10.1056/NEJM200007133430201
  30. Liu L, Yuan P, Liu L, et al (2011a). A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat, 125, 479-87. https://doi.org/10.1007/s10549-010-0959-z
  31. Liu L, Yuan P, Wu C, et al (2011b). A functional- 77T> C polymorphism in XRCC1 is associated with risk of breast cancer. Breast cancer Res Treat, 125, 479-87. https://doi.org/10.1007/s10549-010-0959-z
  32. Loizidou MA, Michael T, Neuhausen SL, et al (2008). Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res Treat, 112, 575-9. https://doi.org/10.1007/s10549-007-9881-4
  33. Luo H, Li Z, Qing Y, et al (2014). Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population. Asian Pac J Cancer Prev, 15, 1133-40. https://doi.org/10.7314/APJCP.2014.15.3.1133
  34. Macias-Gomez NM, Peralta-Leal V, Meza-Espinoza JP, et al (2015). Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population. Fam Cancer, 14, 349-54. https://doi.org/10.1007/s10689-015-9787-y
  35. McCullough LE, Santella RM, Cleveland RJ, et al (2014). Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk. Int J Cancer, 134, 654-63. https://doi.org/10.1002/ijc.28383
  36. Metsola K, Kataja V, Sillanpaa P, et al (2005). XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res, 7, 987-97. https://doi.org/10.1186/bcr1333
  37. Ming-Shiean H, Yu JC, Wang HW, et al (2010). Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann Surg Oncol, 17, 760-71. https://doi.org/10.1245/s10434-009-0802-0
  38. Mitra AK, Singh N, Singh A, et al (2008). Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in North Indian women. Oncol Res, 17, 127-35. https://doi.org/10.3727/096504008785055567
  39. Moullan N, Cox DG, Angele S, et al (2003). Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev, 12, 1168-74.
  40. Pachkowski BF, Winkel S, Kubota Y, et al (2006a). XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res, 66, 2860-8. https://doi.org/10.1158/0008-5472.CAN-05-3388
  41. Pachkowski BF, Winkel S, Kubota Y, et al (2006b). XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res, 66, R2860-8. https://doi.org/10.1158/0008-5472.CAN-05-3388
  42. Patel AV, Calle EE, Pavluck AL, et al (2005a). A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res, 7, 1168-73. https://doi.org/10.1186/bcr1355
  43. Patel AV, Calle EE, Pavluck AL, et al (2005b). A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res, 7, R1168-73. https://doi.org/10.1186/bcr1355
  44. Patel RK, Trivedi AH, Arora DC, et al (1997). DNA repair proficiency in breast cancer patients and their first-degree relatives. Int J Cancer, 73, 20-4. https://doi.org/10.1002/(SICI)1097-0215(19970926)73:1<20::AID-IJC4>3.0.CO;2-3
  45. Przybylowska-Sygut K, Stanczyk M, Kusinska R, et al (2013a). Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin Breast Cancer, 13, 61-8. https://doi.org/10.1016/j.clbc.2012.09.019
  46. Przybylowska-Sygut K, Stanczyk M, Kusinska R, et al (2013b). Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer. Clin Breast Cancer, 13, 61-8. https://doi.org/10.1016/j.clbc.2012.09.019
  47. Ramadan RA, Desouky LM, Elnaggar MA, et al (2014). Association of DNA repair genes XRCC1 (Arg399Gln), (Arg194Trp) and XRCC3 (Thr241Met) polymorphisms with the risk of breast cancer: a case-control study in Egypt. Genetic Testing & Molecular Biomarkers, 18, 754-60. https://doi.org/10.1089/gtmb.2014.0191
  48. Roberts MR, Shields PG, Ambrosone CB, et al (2011). Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis, 32, 1223-30. https://doi.org/10.1093/carcin/bgr096
  49. Romanowicz-Makowska H, Smolarz B, Kulig A (2007). [Polymorphisms in XRCC1 and ERCC4/XPF DNA repair genes and associations with breast cancer risk in women]. Pol Orthop Traumatol, 22, 200-3.
  50. Romanowicz H, Smolarz B, Baszczynski J, et al (2010). Genetics polymorphism in DNA repair genes by base excision repair pathway (XRCC1) and homologous recombination (XRCC2 and RAD51) and the risk of breast carcinoma in the Polish population. Pol J Pathol, 61, 206-12.
  51. Saadat M, Kohan L, Omidvari S (2008). Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study. Breast Cancer Res Treat, 111, 549-53. https://doi.org/10.1007/s10549-007-9811-5
  52. Sangrajrang S, Schmezer P, Burkholder I, et al (2008). Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat, 111, 279-88. https://doi.org/10.1007/s10549-007-9773-7
  53. Santos RA, Teixeira AC, Mayorano MB, et al (2010). DNA repair genes XRCC1 and XRCC3 polymorphisms and their relationship with the level of micronuclei in breast cancer patients. Genet Mol Biol, 33, 637-40. https://doi.org/10.1590/S1415-47572010005000082
  54. Sapkota Y, Mackey JR, Lai R, et al (2014). Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One, 8, e64896.
  55. Shadrina AS, Ermolenko NA, Boyarskikh UA, et al (2014a). Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study. Clin Exp Med, 16, 21-8.
  56. Shadrina AS, Ermolenko NA, Boyarskikh UA, et al (2014b). Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study. Clin Exp Med, 16, 21-8.
  57. Shen J, Gammon MD, Terry MB, et al (2005). Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 336-42. https://doi.org/10.1158/1055-9965.EPI-04-0414
  58. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8.
  59. Shu XO, Cai Q, Gao YT, et al (2003). A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 12, 1462-7.
  60. Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. https://doi.org/10.3322/caac.21208
  61. Silva SN, Moita R, Azevedo AP, et al (2007a). Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detect Prev, 31, 303-9. https://doi.org/10.1016/j.cdp.2007.07.001
  62. Silva SN, Moita R, Azevedo AP, et al (2007b). Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detect Prev, 31, 303-9. https://doi.org/10.1016/j.cdp.2007.07.001
  63. Smith TR, Levine EA, Freimanis RI, et al (2008). Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis, 29, 2132-8. https://doi.org/10.1093/carcin/bgn193
  64. Smith TR, Levine EA, Perrier ND, et al (2003a). DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1200-4.
  65. Smith TR, Liu-Mares W, Van Emburgh BO, et al (2011). Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer. Carcinogenesis, 32, 1354-60. https://doi.org/10.1093/carcin/bgr117
  66. Smith TR, Miller MS, Lohman K, et al (2003b). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett, 190, 183-90. https://doi.org/10.1016/S0304-3835(02)00595-5
  67. Smolarz B, Makowska M, Samulak D, et al (2014). Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women. Tumour Biol, 35, 3495-502. https://doi.org/10.1007/s13277-013-1461-0
  68. Sobczuk A, Romanowicz-Makowska H, Fiks T, et al (2009a). XRCC1 and XRCC3 DNA repair gene polymorphisms in breast cancer women from the Lodz region of Poland. Pol J Pathol, 60, 76-80.
  69. Sobczuk A, Romanowicz-Makowska H, Fiks T, et al (2009b). XRCC1 and XRCC3 DNA repair gene polymorphisms in breast cancer women from the Lodz region of Poland. Pol J Pathol, 60, 76-80.
  70. Sterpone S, Cornetta T, Padua L, et al (2010a). DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients. Mutat Res Fund Mol Mech Mut, 684, 43-8. https://doi.org/10.1016/j.mrfmmm.2009.11.009
  71. Sterpone S, Mastellone V, Padua L, et al (2010b). Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol, 136, 631-6. https://doi.org/10.1007/s00432-010-0791-1
  72. Sterpone S, Mastellone V, Padua L, et al (2010c). Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol, 136, 631-6. https://doi.org/10.1007/s00432-010-0791-1
  73. Syamala VS, Syamala V, Sreedharan H, et al (2009). Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report. Pathol Oncol Res, 15, 389-97. https://doi.org/10.1007/s12253-008-9135-8
  74. Thyagarajan B, Anderson KE, Folsom AR, et al (2006). No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. Cancer Detect Prev, 30, 313-21. https://doi.org/10.1016/j.cdp.2006.07.002
  75. Wu K, Su D, Lin K, et al (2011). XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Asian Pac J Cancer Prev, 12, 2237-43.
  76. Zhai X, Liu J, Hu Z, et al (2006). Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis. Oncol Rep, 15, 247-52.
  77. Zhang Y, Newcomb PA, Egan KM, et al (2006a). Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 15, 353-8. https://doi.org/10.1158/1055-9965.EPI-05-0653
  78. Zhang Y, Newcomb PA, Egan KM, et al (2006b). Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 15, 353-8. https://doi.org/10.1158/1055-9965.EPI-05-0653
  79. Zipprich J, Terry MB, Brandt-Rauf P, et al (2010). XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study. J Carcinog, 9, 4. https://doi.org/10.4103/1477-3163.62535